(Q45779125)

16 December 2017

title

Analysis of neutralizing antibody specificities of different strains of lymphocytic choriomeningitis virus with strain-specific immune sera (English)

1 reference

16 December 2017

lymphocytic choriomeningitis

main subject

lymphocyte

0 references

1 reference

3

Zinkernagel RM

1 reference

16 December 2017

author name string

Weibel D

series ordinal

1

1 reference

16 December 2017

Bründler MA

series ordinal

2

1 reference

16 December 2017

Battegay M

series ordinal

4

1 reference

16 December 2017

publication date

1 November 1993

1 reference

16 December 2017

published in

Research in Virology

1 reference

16 December 2017

volume

144

1 reference

16 December 2017

issue

6

1 reference

16 December 2017

page(s)

471-478

1 reference

16 December 2017

Selection of genetic variants of lymphocytic choriomeningitis virus in spleens of persistently infected mice. Role in suppression of cytotoxic T lymphocyte response and viral persistence

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Mechanism of recovery from acute virus infection. III. Subclass of T lymphocytes mediating clearance of lymphocytic choriomeningitis virus from the spleens of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Enhancement of disease by neutralizing antiviral antibodies in the absence of primed antiviral cytotoxic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Clearance of lymphocytic choriomeningitis virus in antibody- and B-cell-deprived mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Viral pathogenesis and resistance to defective interfering particles.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

The Immune Response of the Mouse to Lymphocytic Choriomeningitis Virus. I. Circulating Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Studies on cell-mediated immunity to lymphocytic choriomeningitis virus in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Proteins of lymphocytic choriomeningitis virus: antigenic topography of the viral glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Lymphocytic choriomeningitis virus killer T cells are lethal only in weakly disseminated murine infections

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

MENINGITIS IN MAN CAUSED BY A FILTERABLE VIRUS : II. IDENTIFICATION OF THE ETIOLOGICAL AGENT

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Molecular basis of viral persistence: a single amino acid change in the glycoprotein of lymphocytic choriomeningitis virus is associated with suppression of the antiviral cytotoxic T-lymphocyte response and establishment of persistence.

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

Twp populations of T lymphocytes immune to the lymphocytic choriomeningitis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0923-2516%2806%2980062-2

7 January 2021

10.1016/S0923-2516(06)80062-2

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017